MedTrace Logo

Creatine Monohydrate Supplementation and Vascular Endothelial Health

NCT05014659 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2023-01-13

No results posted yet for this study

Summary

To determine the effects of 4 weeks of creatine monohydrate supplementation on markers of macrovascular and microvascular function, cognitive performance, and physical performance.

Conditions

  • Endothelial Dysfunction
  • Oxidative Stress

Interventions

DIETARY_SUPPLEMENT

Creatine monohydrate

4 x 5g doses daily for 5 days, followed by 1 x 5g dose daily for 23 days.

DIETARY_SUPPLEMENT

Placebo

4 x 5g doses daily for 5 days, followed by 1 x 5g dose daily for 23 days.

Sponsors & Collaborators

  • Florida State University

    lead OTHER

Principal Investigators

  • Holly E Clarke, PhD · Florida State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-17
Primary Completion
2022-12-12
Completion
2022-12-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05014659 on ClinicalTrials.gov